Cancer

70-gene signature not cost-effective in breast cancer

(HealthDay)—For patients with node-negative breast cancer (NNBC), the 70-gene signature is unlikely to be cost-effective for guiding adjuvant chemotherapy decision making, according to a study published ...

Oct 18, 2014
popularity 3 / 5 (2) | comments 0

Modeling tumor dormancy

Cancer constantly wages war on the human body. Battles are won, lost or sometimes end in a stalemate. In pancreatic cancer, this stalemate—known as tumor dormancy—can last up to 25 years before becoming ...

Oct 16, 2014
popularity not rated yet | comments 0

Immune therapy induces remission for many with ALL

(HealthDay)—An experimental immune-system therapy can often lead to complete remission in advanced acute lymphoblastic leukemia (ALL) patients who have run out of other options, according to research published ...

Oct 16, 2014
popularity not rated yet | comments 0

Team discovers stem cells in the esophagus

Despite previous indications to the contrary, the esophagus does have its own pool of stem cells, said researchers from the University of Pittsburgh School of Medicine in an animal study published online today in Cell Re ...

Oct 16, 2014
popularity not rated yet | comments 0